Purav Patel, Director at REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), bought 3,000 shares at $4.69 ($14K) on 2022-11-18, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.